MBOT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MBOT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Microbot Medical has the GF Value Rank of 0.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Microbot Medical's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Rachel Vaknin | officer: Chief Financial Officer | DROR 3/10, ZICHRON YAAKOV L3 3090216 |
Simon Sharon | officer: General Manager & CTO | 8 HAMADA STREET, ZICHRON YAACOV L3 3090708 |
Yoseph Bornstein | director, 10 percent owner | 16 IRUS STREET, ROSH HA'AYIN L3 4858022 |
Tal Baruch Wenderow | director | 1149, BEACON STREET, NEWTON MA 02461 |
Eyal Morag | officer: Chief Medical Officer | BONEY HAEAR 3 STREET, APT #13, TEL AVIV L3 6937303 |
Aileen Ptucha Stockburger | director | 26 WELLINGTON CT, BELLE MEADE NJ 08502 |
Harel Gadot | director, 10 percent owner, officer: Chairman and CEO | 5 VILLAGE LANE, HINGHAM MA 02043 |
Joseph Mona | 10 percent owner | 808 HAMPTON ST, COLUMBIA SC 29201 |
Prattipati Laxminarain | director | 3 HEWINS FARM ROAD, WELLESLEY MA 02481 |
Yoav Zvi Waizer | director | 8 HAVERED STREET, RAANANA L3 4352308 |
Moshe Shoham | director | 22 BEDOLACH STREET, HOSHAYA L3 1791500 |
Leon Lewkowicz | 10 percent owner | GORDON STREET 10, APARTMENT 7, TEL-AVIV L3 63458 |
Martin J. Madden | director | C/O MICROBOT MEDICAL INC., 175 DERBY STREET 27/1, HINGHAM MA 02043 |
Yehezkel Himelfarb | officer: General Manager & COO | 32 BEN YOSEF STREET, TEL-AVIV L3 6912530 |
Sandra Berkson | 10 percent owner | C/O SABER HOLDING GMBH, WEIN KRUMMBAUMGASSE C4 1020 |
From GuruFocus
By GuruFocus Research • 02-07-2024
By Marketwired • 09-27-2023
By Marketwired • 07-08-2024
By Marketwired • 04-15-2024
By Marketwired • 10-15-2024
By Marketwired • 10-19-2023
By Marketwired • 08-01-2024
By Marketwired • 10-17-2023
By Marketwired • 08-13-2024
By Marketwired • 06-29-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.